December 26, 2014 4:47 PM ET

Healthcare Equipment and Supplies

Company Overview of Sequenom Center for Molecular Medicine, LLC

Executive Profile

Paul W. Hawran

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships
61--

Background

Mr. Paul W. Hawran serves as Chief Financial Officer of Sequenom Center for Molecular Medicine, LLC. Mr. Hawran served as the Chief Financial Officer of Sequenom Inc. from April 1, 2007 to November 2009 and also served as its Principal Accounting Officer. He served as a Consultant of Sequenom Inc. Mr. Hawran served as an Advisor of Neurocrine Biosciences Inc. from September 2006 to March 2007, Chief Financial Officer from January 2001 to September 2006 and also served ...

Corporate Headquarters

301 Michigan Street NE
Grand Rapids, Michigan 49503

United States

Phone: 616-391-4330
Fax: 616-284-3838

Board Members Memberships

2005-Present
Independent Director, Chairman of Audit Committee and Member of Compensation Committee
2006-2007
Former Chief Financial Officer and Principal Accounting Officer

Education

MS
Seton Hall University
BS
St. John's University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sequenom Center for Molecular Medicine, LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.